After a Type 2 Diabetes Diagnosis, Does Improving Diet Quality Affect Longevity?
A new long-term study offers an encouraging message for people living with type 2 diabetes: people whose eating patterns scored higher for quality after diagnosis, or improved more over time, had lower observed mortality during follow-up. The study does not show that a particular diet caused people to live longer. It does not prove that […]
A New Genetic Clue About Diabetes and Kidney Disease—Plus the Kidney Care That Exists Now
A new study has identified the circulating protein INHBC as a possible link between type 2 diabetes and chronic kidney disease. It is an early research lead, not a treatment, validated blood test, or reason to change medication. The actionable message remains familiar: kidney disease can develop without obvious symptoms, so regular blood and urine […]
Frequent Urination and Thirst: When Diabetes May Be One Possibility—and Why Testing Matters
Needing to urinate more often than usual—especially if it is paired with unusual thirst—can be a sign that blood glucose is elevated. It can also have many other causes, including increased fluid intake, urinary tract infection, medications, prostate conditions, pregnancy, sleep disorders, and other health issues. That is why symptoms should prompt a health conversation, […]
A New Clue Linking Diabetic Eye and Kidney Complications: Promising Biology, Not Yet a Treatment
Diabetes can affect many parts of the body, but two complications often travel together: diabetic eye disease and diabetic kidney disease. Both are shaped by long-term metabolic stress and injury to small blood vessels. Researchers have long suspected that they may also share deeper biological pathways. A new PLOS Biology study offers a detailed clue […]
GLP-1 Medicines in Type 2 Diabetes: What a New Consensus Supports—and What They Do Not Replace
GLP-1 receptor agonists are often discussed as if they are a single answer to a very complicated condition. In reality, they are one category of prescription medicines that may help selected people with type 2 diabetes, obesity, chronic kidney disease, or cardiovascular risk. The decision to use one depends on the person’s medical history, treatment […]
Tirzepatide and Cardiovascular Risk: What New Evidence—and the Updated Mounjaro Label—Mean for Type 2 Diabetes Care
Tirzepatide, sold as Mounjaro for type 2 diabetes in the United States, has become a major part of the public conversation about diabetes and metabolic health. Recent reporting has focused on two related developments: a large real-world study linking tirzepatide with fewer major cardiovascular events than a cardiovascular-neutral comparison medicine, and a new Mounjaro indication […]
Sleep and Type 2 Diabetes: Why Sleep Quality Belongs in a Whole-Person Care Plan
When people talk about managing type 2 diabetes, the conversation usually turns to food, medications, physical activity, or glucose monitoring. Sleep is often left out—despite the fact that poor sleep can affect energy, mood, appetite, activity, and the ability to follow through on every other part of a care plan. A new study adds to […]
The Muscle Molecule Released With Exercise: What L-BAIBA Research Means for Type 2 Diabetes Care
When people hear that exercise is useful for type 2 diabetes, they may think first about calories, weight loss, or “earning” food. That framing misses much of the biology—and it can make movement feel like a punishment. Muscles are active metabolic organs. When they contract, they use glucose, communicate with other tissues, adapt to training, […]
Type 2 Diabetes and Brain Health: What Recent Studies on Blood Sugar and Medications Can—and Cannot—Tell Us
Type 2 diabetes is often discussed through blood glucose, weight, A1c, blood pressure, or cholesterol. Those measures matter. But people living with diabetes are also asking a broader question: What does metabolic health mean for the brain over time? Brain health belongs in the type 2 diabetes conversation That question has become more urgent as […]
Earlier Risk Stratification in Diabetic Kidney Disease May Help Teams Target Care—What a New Real-World Study Shows
Kidney disease is one of the most serious complications associated with type 2 diabetes, yet it can progress quietly. A person may feel well while urine albumin changes, estimated glomerular filtration rate (eGFR) declines, blood pressure rises, or cardiovascular risk increases. That is why early screening and risk assessment matter. They give the care team […]